Clementi Nicola

Nicola Clementi is an Associate Professor at Vita-Salute San Raffaele University, School of Medicine, Department of Medical Microbiology and Virology. He holds concurrent roles as a Microbiology and Virology Specialist at IRCCS San Raffaele Hospital in Milan.

• Board Certified in Medical Microbiology and Virology (2010)
• National Scientific Habilitation as Full Professor (2020-2030) and Associate Professor (2017-2027) in Microbiology and Clinical Microbiology
• Key research areas: Human monoclonal antibody engineering, viral pathogenesis, antimicrobial resistance, and metagenomic diagnostics

Research Focus includes molecular dissection of humoral immunity against HIV, HCV, influenza, HSV, and multidrug-resistant pathogens. His work spans epitope-based vaccine development, antibody pharmacokinetic engineering, and in vivo antiviral efficacy, with recent emphasis on SARS-CoV-2 variant tracking and mpox epidemiology.

Recent article trends highlight expertise in:

• SARS-CoV-2 genomic surveillance (2025: Omicron era epidemiology, JN.1 variants)
• Antimicrobial resistance (2024: Ribavirin aerosol for SARS-CoV-2, 2023: IN SIGNO project)
• Viral immune evasion (2016: HSV entry processes, 2014: HCV neutralization)
• Metagenomic diagnostics (2024: Bacterial/fungal metagenomics, 2025: Group A Streptococcus)

Scientific Awards: Recipient of the 2017 LURIA AWARD from the Italian Society for Virology. Editorial roles include Review Editor for Frontiers in Microbiology and Guest Associate Editor for Frontiers in Pharmacology.

Academic Leadership: Coordinated courses at International MD Program, RBM, and BMB degree programs. Currently directs the Molecular Microbiology and Drug-Resistance Sequencing Unit at San Raffaele Hospital, managing SARS-CoV-2 whole-genome sequencing since 2020.